Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Prostaglandin E2 receptor 4 (EP4) is a prostaglandin receptor encoded by the PTGER4 gene. The activity of the receptor is mediated by G proteins that stimulate adenylate cyclase. It has a relaxing effect on smooth muscle. It plays an important role in regulating renal hemodynamics, intestinal epithelial transport, adrenal aldosterone secretion, and uterine function.

The Prostaglandin E2 receptor 4 (EP4) pipeline market research report provides comprehensive information on the therapeutics under development for Prostaglandin E2 receptor 4 (EP4), complete with analysis by stage of development, drug therapy areas, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Prostaglandin E2 receptor 4 (EP4) and features dormant and discontinued projects.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Segmentation by Therapy Areas

The key therapy areas in the Prostaglandin E2 receptor 4 (EP4) pipeline products market are oncology, immunology, central nervous system, musculoskeletal disorders, respiratory, women’s health, gastrointestinal, and others.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Analysis by Therapy Areas, 2022 (%)

For more therapy area insights into the Prostaglandin E2 receptor 4 (EP4) pipeline products market, download a free report sample

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Segmentation by Mechanisms of Action

The key MoA in the Prostaglandin E2 receptor 4 (EP4) pipeline products market are Prostaglandin E2 Receptor EP4 Subtype Antagonist and Prostaglandin E2 Receptor EP4 Subtype Agonist.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Analysis by Mechanisms of Action, 2022 (%)

For more mechanisms of action insights into the Prostaglandin E2 receptor 4 (EP4) pipeline products market, download a free report sample

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Segmentation by Routes of Administration

The key RoA in the Prostaglandin E2 receptor 4 (EP4) pipeline products market are oral, topical, and intravenous.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Analysis by Routes of Administration, 2022 (%)

For more routes of administration insights into the Prostaglandin E2 receptor 4 (EP4) pipeline products market, download a free report sample

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Segmentation by Molecule Types

The key molecule types in the Prostaglandin E2 receptor 4 (EP4) pipeline products market are monoclonal antibody and small molecule.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Analysis by Molecule Types, 2022 (%)

For more molecule type insights into the Prostaglandin E2 receptor 4 (EP4) pipeline products market, download a free report sample

Competitive Landscape

Some of the leading companies in the Prostaglandin E2 receptor 4 (EP4) pipeline products market are AskAt Inc, Domain Therapeutics SA, Draconis Pharma SL, Eisai Co Ltd, Exalys Therapeutics Inc, GSK plc, Gurus BioPharm Inc, Ionova Life Science Co Ltd.

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Analysis by Companies, 2022 (%)

To know more about the leading companies in the Prostaglandin E2 receptor 4 (EP4) pipeline products market, download a free report sample

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Report Overview

Segments Covered in the Report

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Therapy Areas Outlook

• Oncology
• Immunology
• Central Nervous System
• Musculoskeletal Disorders
• Respiratory
• Women’s Health
• Gastrointestinal

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Mechanisms of Action Outlook

• Prostaglandin E2 Receptor EP4 Subtype Antagonist
• Prostaglandin E2 Receptor EP4 Subtype Agonist

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Routes of Administration Outlook

• Oral
• Topical
• Intravenous

Prostaglandin E2 receptor 4 (EP4) Pipeline Products Market Molecule Types Outlook

• Monoclonal Antibody
• Small Molecule

Scope

• The report provides a snapshot of the global therapeutic landscape for Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4)
• The report reviews Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
• The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
• The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
• The report reviews key players involved in Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics and enlists all their major and minor projects
• The report assesses Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
• The report summarizes all the dormant and discontinued pipeline projects
• The report reviews latest news and deals related to Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) targeted therapeutics

Reasons to Buy

• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
• Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
• Identify and understand the targeted therapy areas and indications for Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4)Identify the use of drugs for target identification and drug repurposing
• Identify potential new clients or partners in the target demographic
• Develop strategic initiatives by understanding the focus areas of leading companies
• Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
• Devise corrective measures for pipeline projects by understanding Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) development landscape
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope